vs

Side-by-side financial comparison of Eastman Chemical Company (EMN) and PACS Group, Inc. (PACS). Click either name above to swap in a different company.

Eastman Chemical Company is the larger business by last-quarter revenue ($2.0B vs $1.4B, roughly 1.5× PACS Group, Inc.). Eastman Chemical Company runs the higher net margin — 5.3% vs 4.4%, a 0.9% gap on every dollar of revenue. On growth, PACS Group, Inc. posted the faster year-over-year revenue change (18.4% vs -13.8%). Over the past eight quarters, PACS Group, Inc.'s revenue compounded faster (20.5% CAGR vs -8.6%).

Eastman Chemical Company is an American chemical products manufacturer based in Kingsport, Tennessee. Founded in 1920, it was formerly a subsidiary of Kodak until 1994. The company is an independent global specialty materials company that produces a broad range of advanced materials, chemicals and fibers for everyday purposes. It operates 36 manufacturing sites worldwide and employs approximately 14,000 people. In 2023, Eastman had sales revenue of approximately $9.21 billion.

EMN vs PACS — Head-to-Head

Bigger by revenue
EMN
EMN
1.5× larger
EMN
$2.0B
$1.4B
PACS
Growing faster (revenue YoY)
PACS
PACS
+32.2% gap
PACS
18.4%
-13.8%
EMN
Higher net margin
EMN
EMN
0.9% more per $
EMN
5.3%
4.4%
PACS
Faster 2-yr revenue CAGR
PACS
PACS
Annualised
PACS
20.5%
-8.6%
EMN

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
EMN
EMN
PACS
PACS
Revenue
$2.0B
$1.4B
Net Profit
$105.0M
$59.7M
Gross Margin
17.1%
Operating Margin
7.0%
Net Margin
5.3%
4.4%
Revenue YoY
-13.8%
18.4%
Net Profit YoY
-42.3%
3022.5%
EPS (diluted)
$0.93
$0.42

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EMN
EMN
PACS
PACS
Q1 26
$2.0B
Q4 25
$2.0B
$1.4B
Q3 25
$2.2B
$1.3B
Q2 25
$2.3B
$1.3B
Q1 25
$2.3B
$1.3B
Q4 24
$2.2B
$1.1B
Q3 24
$2.5B
$1.0B
Q2 24
$2.4B
$981.4M
Net Profit
EMN
EMN
PACS
PACS
Q1 26
$105.0M
Q4 25
$105.0M
$59.7M
Q3 25
$47.0M
$52.4M
Q2 25
$140.0M
$51.0M
Q1 25
$182.0M
$28.5M
Q4 24
$330.0M
$1.9M
Q3 24
$180.0M
$15.6M
Q2 24
$230.0M
$-10.9M
Gross Margin
EMN
EMN
PACS
PACS
Q1 26
17.1%
Q4 25
17.1%
Q3 25
19.7%
Q2 25
22.1%
Q1 25
24.8%
Q4 24
24.7%
Q3 24
24.6%
17.1%
Q2 24
25.3%
22.3%
Operating Margin
EMN
EMN
PACS
PACS
Q1 26
Q4 25
0.6%
7.0%
Q3 25
6.1%
6.4%
Q2 25
7.4%
6.2%
Q1 25
11.0%
3.8%
Q4 24
13.2%
1.7%
Q3 24
11.4%
2.2%
Q2 24
12.1%
0.1%
Net Margin
EMN
EMN
PACS
PACS
Q1 26
5.3%
Q4 25
5.3%
4.4%
Q3 25
2.1%
3.9%
Q2 25
6.1%
3.9%
Q1 25
7.9%
2.2%
Q4 24
14.7%
0.2%
Q3 24
7.3%
1.5%
Q2 24
9.7%
-1.1%
EPS (diluted)
EMN
EMN
PACS
PACS
Q1 26
$0.93
Q4 25
$0.93
$0.42
Q3 25
$0.40
$0.32
Q2 25
$1.20
$0.31
Q1 25
$1.57
$0.17
Q4 24
$2.81
$-0.03
Q3 24
$1.53
$0.10
Q2 24
$1.94
$-0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EMN
EMN
PACS
PACS
Cash + ST InvestmentsLiquidity on hand
$566.0M
$197.0M
Total DebtLower is stronger
$353.2M
Stockholders' EquityBook value
$6.0B
$946.8M
Total Assets
$14.9B
$5.6B
Debt / EquityLower = less leverage
0.37×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EMN
EMN
PACS
PACS
Q1 26
$566.0M
Q4 25
$566.0M
$197.0M
Q3 25
$355.7M
Q2 25
$294.2M
Q1 25
$287.5M
Q4 24
$837.0M
$157.7M
Q3 24
$49.5M
Q2 24
$73.4M
Total Debt
EMN
EMN
PACS
PACS
Q1 26
Q4 25
$353.2M
Q3 25
Q2 25
Q1 25
Q4 24
$411.9M
Q3 24
Q2 24
Stockholders' Equity
EMN
EMN
PACS
PACS
Q1 26
$6.0B
Q4 25
$6.0B
$946.8M
Q3 25
$5.8B
$871.3M
Q2 25
$5.8B
$806.8M
Q1 25
$5.9B
$750.2M
Q4 24
$5.8B
$709.6M
Q3 24
$5.7B
$660.0M
Q2 24
$5.6B
$572.1M
Total Assets
EMN
EMN
PACS
PACS
Q1 26
$14.9B
Q4 25
$14.9B
$5.6B
Q3 25
$15.0B
$5.6B
Q2 25
$15.2B
$5.5B
Q1 25
$15.0B
$5.5B
Q4 24
$15.2B
$5.2B
Q3 24
$15.1B
$4.5B
Q2 24
$14.9B
$3.9B
Debt / Equity
EMN
EMN
PACS
PACS
Q1 26
Q4 25
0.37×
Q3 25
Q2 25
Q1 25
Q4 24
0.58×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EMN
EMN
PACS
PACS
Operating Cash FlowLast quarter
$-3.4M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
-0.06×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EMN
EMN
PACS
PACS
Q1 26
Q4 25
$502.0M
$-3.4M
Q3 25
$402.0M
$204.8M
Q2 25
$233.0M
$52.6M
Q1 25
$-167.0M
$150.2M
Q4 24
$540.0M
$64.6M
Q3 24
$396.0M
$209.2M
Q2 24
$367.0M
$34.8M
Free Cash Flow
EMN
EMN
PACS
PACS
Q1 26
Q4 25
$390.0M
Q3 25
$265.0M
Q2 25
$83.0M
Q1 25
$-314.0M
Q4 24
$361.0M
Q3 24
$276.0M
Q2 24
$252.0M
FCF Margin
EMN
EMN
PACS
PACS
Q1 26
Q4 25
19.8%
Q3 25
12.0%
Q2 25
3.6%
Q1 25
-13.7%
Q4 24
16.1%
Q3 24
11.2%
Q2 24
10.7%
Capex Intensity
EMN
EMN
PACS
PACS
Q1 26
Q4 25
5.7%
Q3 25
6.2%
Q2 25
6.6%
Q1 25
6.4%
Q4 24
8.0%
Q3 24
4.9%
Q2 24
4.9%
Cash Conversion
EMN
EMN
PACS
PACS
Q1 26
Q4 25
4.78×
-0.06×
Q3 25
8.55×
3.91×
Q2 25
1.66×
1.03×
Q1 25
-0.92×
5.28×
Q4 24
1.64×
33.78×
Q3 24
2.20×
13.39×
Q2 24
1.60×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons